Tentarix Biotherapeutics

About Tentarix Biotherapeutics

Tentarix Biotherapeutics is a biotech startup that specializes in the development of multifunctional biologics, which are substances used for treatment, prevention, or cure of diseases. The company's unique approach involves directing powerful biological activities, such as cell activation and proliferation, specifically to cell types that drive therapeutic benefits. This targeted approach aims to maximize the therapeutic benefits while minimizing the impact on other cells that could limit these benefits.

The company's business model revolves around the screening of millions of molecules and a platform based on cell surface proteomics, binder generation, and combinatorial assembly and identification of multifunctional biologics. These processes involve studying proteins on the cell surface, creating binders that can attach to these proteins, and assembling and identifying biologics that can perform multiple functions.

Tentarix's multifunctional biologics are not based on natural ligands, but on fully human antibody components. This makes their manufacturing process more robust and industrialized, based on decades of process development.

The company's clients are likely to be in the healthcare and pharmaceutical industries, including hospitals, clinics, and drug manufacturers. The company makes money by developing and selling these multifunctional biologics to its clients.

The company's leadership, including Stephen Demarest, brings a wealth of experience in antibody and multi-specific protein development, having contributed to more than 10 molecules that reached IND-enabling studies.